Patents by Inventor Benson Edagwa

Benson Edagwa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240100171
    Abstract: The present invention provides prodrugs and methods of use thereof.
    Type: Application
    Filed: October 27, 2022
    Publication date: March 28, 2024
    Inventors: Howard E. Gendelman, Benson Edagwa
  • Patent number: 11839623
    Abstract: The present invention provides prodrugs and methods of use thereof.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: December 12, 2023
    Assignee: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
    Inventors: Howard E. Gendelman, Benson Edagwa
  • Patent number: 11458136
    Abstract: The present invention provides prodrugs and methods of use thereof.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: October 4, 2022
    Assignee: Board of Regents of the University of Nebraska
    Inventors: Howard E. Gendelman, Benson Edagwa
  • Publication number: 20220288037
    Abstract: The present invention provides prodrugs and methods of use thereof.
    Type: Application
    Filed: August 21, 2020
    Publication date: September 15, 2022
    Inventors: Benson Edagwa, Howard Gendelman
  • Publication number: 20220211716
    Abstract: The present invention provides prodrugs and methods of use thereof.
    Type: Application
    Filed: March 18, 2022
    Publication date: July 7, 2022
    Inventors: Howard Gendelman, Benson Edagwa
  • Publication number: 20220211714
    Abstract: The present invention provides compositions and methods for the delivery of antivirals to a cell or subject.
    Type: Application
    Filed: March 16, 2022
    Publication date: July 7, 2022
    Inventors: Howard E. Gendelman, Xin-Ming Liu, Benson Edagwa
  • Publication number: 20220175936
    Abstract: The present invention provides prodrugs and methods of use thereof.
    Type: Application
    Filed: November 27, 2019
    Publication date: June 9, 2022
    Inventors: Howard Gendelman, Benson Edagwa
  • Patent number: 11311547
    Abstract: The present invention provides prodrugs and methods of use thereof.
    Type: Grant
    Filed: May 24, 2021
    Date of Patent: April 26, 2022
    Assignee: Board of Regents of the University of Nebraska
    Inventors: Howard Gendelman, Benson Edagwa
  • Patent number: 11311545
    Abstract: The present invention provides compositions and methods for the delivery of antivirals to a cell or subject.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: April 26, 2022
    Assignee: Board of Regents of the University of Nebraska
    Inventors: Howard E. Gendelman, Xin-Ming Liu, Benson Edagwa
  • Patent number: 11166957
    Abstract: The present invention provides prodrugs and methods of use thereof.
    Type: Grant
    Filed: May 24, 2021
    Date of Patent: November 9, 2021
    Assignee: Board of Regents of the University of Nebraska
    Inventors: Howard Gendelman, Benson Edagwa
  • Patent number: 11154557
    Abstract: The present invention provides prodrugs and methods of use thereof.
    Type: Grant
    Filed: March 22, 2021
    Date of Patent: October 26, 2021
    Assignee: Board of Regents of the University of Nebraska
    Inventors: Howard Gendelman, Benson Edagwa
  • Publication number: 20210322425
    Abstract: The present invention provides prodrugs and methods of use thereof.
    Type: Application
    Filed: May 24, 2021
    Publication date: October 21, 2021
    Inventors: Howard Gendelman, Benson Edagwa
  • Publication number: 20210275535
    Abstract: The present invention provides prodrugs and methods of use thereof.
    Type: Application
    Filed: May 24, 2021
    Publication date: September 9, 2021
    Inventors: Howard Gendelman, Benson Edagwa
  • Publication number: 20210213023
    Abstract: The present invention provides prodrugs and methods of use thereof.
    Type: Application
    Filed: March 22, 2021
    Publication date: July 15, 2021
    Inventors: Howard Gendelman, Benson Edagwa
  • Publication number: 20210113558
    Abstract: The present invention provides prodrugs and methods of use thereof.
    Type: Application
    Filed: April 9, 2019
    Publication date: April 22, 2021
    Applicant: Board of Regents of the University of Nebraska
    Inventors: Howard E. GENDELMAN, Benson EDAGWA
  • Publication number: 20210060138
    Abstract: Methods of eliminating a retrovirus from a subject utilize nanoformulated anti-retroviral compounds and gene editing agents. Compositions comprise at least one anti-retroviral compounds, at least one gene-editing agent, or combinations thereof.
    Type: Application
    Filed: March 6, 2020
    Publication date: March 4, 2021
    Applicants: Temple University - of the Commonwealth System of Higher Education, BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA, BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
    Inventors: Kamel Khalili, Howard E. Gendelman, Benson Edagwa
  • Publication number: 20200390796
    Abstract: The present invention provides prodrugs and methods of use thereof.
    Type: Application
    Filed: January 14, 2019
    Publication date: December 17, 2020
    Inventors: Howard E. Gendelman, Benson Edagwa
  • Publication number: 20170304308
    Abstract: The present invention provides compositions and methods for the delivery of antivirals to a cell or subject.
    Type: Application
    Filed: October 9, 2015
    Publication date: October 26, 2017
    Inventors: Howard E. Gendelman, Xin-Ming Liu, Benson Edagwa